Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
AVCO

AVCO - Avalon GloboCare Corp Stock Price, Fair Value and News

0.39USD0.00 (0.00%)Market Closed
Watchlist

Market Summary

USD0.390.00
Market Closed
0.00%

AVCO Stock Price

View Fullscreen

AVCO RSI Chart

AVCO Valuation

Market Cap

4.3M

Price/Earnings (Trailing)

-0.45

Price/Sales (Trailing)

112.06

EV/EBITDA

-0.46

Price/Free Cashflow

-0.56

AVCO Price/Sales (Trailing)

AVCO Profitability

EBT Margin

-22934.48%

Return on Equity

-56.89%

Return on Assets

-31.93%

Free Cashflow Yield

-179.38%

AVCO Fundamentals

AVCO Revenue

Revenue (TTM)

40.2K

AVCO Earnings

Earnings (TTM)

-9.6M

Earnings Growth (Yr)

72.57%

Earnings Growth (Qtr)

45.94%

Breaking Down AVCO Revenue

Last 7 days

-9.5%

Last 30 days

-13.6%

Last 90 days

-33.3%

Trailing 12 Months

26.3%

How does AVCO drawdown profile look like?

AVCO Financial Health

Current Ratio

0.13

AVCO Investor Care

Shares Dilution (1Y)

10.87%

Diluted EPS (TTM)

-0.92

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202100040.2K
20200000
20194.6M4.8M6.0M0
20181.7M2.3M3.0M3.7M
20170001.0M

Tracking the Latest Insider Buys and Sells of Avalon GloboCare Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Aug 05, 2022
lu wenzhao
acquired
350,000
0.78
448,718
-
Jul 25, 2022
lu wenzhao
acquired
2,888,590
0.65
4,443,990
-
Jul 25, 2022
lu wenzhao
acquired
2,887,940
0.65
4,442,990
-
Jul 18, 2022
lu wenzhao
acquired
2,886,250
0.65
4,440,390
-
Dec 21, 2021
lu wenzhao
acquired
3,000,000
1.25
2,400,000
-
Apr 01, 2020
lu wenzhao
bought
1,000,000
1.55
645,161
-
Jun 07, 2019
lu wenzhao
bought
27,600
1.84
15,000
-
Jun 06, 2019
lu wenzhao
bought
42,630
2.03
21,000
-
Apr 18, 2019
lu wenzhao
bought
-2,000,000
1.00
-2,000,000
-
Apr 18, 2019
lu wenzhao
sold
-2,000,000
1.00
-2,000,000
-

1–10 of 10

Which funds bought or sold AVCO recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Feb 14, 2024
STATE STREET CORP
unchanged
-
-5,985
9,235
-%
Feb 14, 2024
BANK OF AMERICA CORP /DE/
new
-
34.00
34.00
-%
Feb 14, 2024
TWO SIGMA SECURITIES, LLC
new
-
6,952
6,952
-%
Feb 14, 2024
MILLENNIUM MANAGEMENT LLC
new
-
6,103
6,103
-%
Feb 14, 2024
VANGUARD GROUP INC
reduced
-17.66
-33,651
33,060
-%
Feb 14, 2024
Royal Bank of Canada
unchanged
-
-
-
-%
Feb 13, 2024
Tower Research Capital LLC (TRC)
added
2.04
-2,479
3,938
-%
Feb 13, 2024
MORGAN STANLEY
added
4.00
-60.00
101
-%
Feb 13, 2024
BlackRock Inc.
sold off
-100
-2,007
-
-%

1–10 of 18

Are Funds Buying or Selling AVCO?

Are funds buying AVCO calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own AVCO
No. of Funds

Unveiling Avalon GloboCare Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Jan 25, 2024
lu wenzhao
33.9%
3,733,788
SC 13D/A

Recent SEC filings of Avalon GloboCare Corp

View All Filings
Date Filed Form Type Document
Jan 25, 2024
SC 13D/A
13D - Major Acquisition
Nov 22, 2023
8-K
Current Report
Nov 14, 2023
10-Q
Quarterly Report

Avalon GloboCare Corp News

Latest updates
GlobeNewswire15 months ago

Avalon GloboCare Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q22018Q12017Q42017Q32017Q2
Revenue------1,753,1821,722,5931,692,0051,661,4161,630,827792,4861,468,2262,079,372413,503593,025571,772443,528315,284152,497
Gross Profit-42.0%97,853168,70075,08572,880130,084189,16128,50342,455196,78653,22879,89210,007412,497-7,202-17,281-32,18844,867-27,266
Costs and Expenses-25.7%236,349318,064--324,473135,821272,764254,501282,412329,988319,835274,157289,248295,481362,749226,794215,366227,755287,085
Operating Expenses10.6%2,360,8442,133,6712,377,3652,376,4683,168,5263,379,7193,031,3303,264,6475,288,6045,529,5754,423,6444,475,3202,779,2732,497,4401,346,5981,395,8382,442,040--
  S&GA Expenses-----------------1151486,279
  R&D Expenses55.7%348,956224,072238,793213,188208,920238,432161,101275,402414,559265,139949,711152,460-1,384263----
EBITDA Margin-13535.0%-216-1.59-1.80-1.91-2.06-2.35-------------
Interest Expenses----------3,1612,3568,82225,697157,63525,2051,300408244--
Earnings Before Taxes-15.3%-2,334,252-2,024,219-2,364,910-2,367,118-3,100,316-3,251,959-3,056,382-3,270,781-4,792,351-4,334,058-4,438,823-4,504,929-2,754,261-2,403,251-1,343,815-1,550,969-2,359,075--
EBT Margin-13583.3%-225-1.65-1.86-1.97-2.12-2.41-------------
Net Income-15.3%-2,334,252-2,024,219-2,364,910-2,367,118-3,100,316-3,251,959-3,056,382-3,270,781-4,792,351-4,334,058-4,438,823-4,504,929-2,754,261-2,403,251-1,343,815-1,550,969-2,359,075--
Net Income Margin-13583.3%-225-1.65-1.86-1.97-2.12-2.41-------------
Free Cashflow-Infinity%-1,717,012------------------
Balance Sheet
(In Thousands)
Balance Sheet
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets-0.9%29,96730,23130,83619,75212,91110,2759,66910,24210,39410,37811,28510,36611,15610,75910,34810,49110,66913,63312,72913,39614,842
  Current Assets-39.3%8641,4231,3912,3744,4491,6539141,3231,2581,3252,1641,2862,1531,8321,3481,5711,8073,9922,9233,6255,312
    Cash Equivalents-47.7%3426538871,9913,9381,1805268085326851,6937271,3961,2496357651,0723,4011,7692,2523,810
  Inventory------------------13.0017.0013.0027.00
  Net PPE-65.7%40.00117140138214266321362400443440479501520555601625375399250272
Liabilities5.8%13,14512,41911,0628,5938,33410,1018,3887,1588,5407,1496,6386,2495,8136,0176,6386,0254,9225,0913,6642,1422,158
  Current Liabilities12.2%6,6925,9655,1763,5803,3287,2105,1484,4024,5363,6803,2242,5922,4392,6273,0332,8354,3321,0352,6641,1421,158
Shareholder's Equity-5.6%16,82317,81219,77511,1594,5771741,2813,0841,8543,2294,6474,1175,3434,7423,7104,4655,7477,8429,06511,25412,684
  Retained Earnings-2.2%-70,214-68,729-65,982-63,062-60,645-55,230-53,202-51,131-48,797-46,773-44,408-42,041-38,941-35,689-32,632-29,361-25,431-20,054-15,697-11,291-8,638
  Additional Paid-In Capital0.7%67,78167,27766,48165,95065,37256,11955,15354,88951,33650,68849,75646,85645,02941,21637,13134,59331,98430,37626,42624,15322,823
Shares Outstanding-4.2%10,01410,44810,1649,9629,7048,8728,8508,8468,5368,4628,3418,2288,062--------
Minority Interest------------------1,513-1,042-962-862-762
Float------15,433---30,394---48,343---57,605---
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations46.6%-1,348-2,524-1,834-1,964-2,386-2,175-511-1,716-713-1,078-1,515-1,360-2,260-1,926-1,998-1,761-1,397-2,497-1,422-855-1,340
  Share Based Compensation-65.0%1895403271241622166064895355135741,5291,5161,2601,1892,2062,2852,4452,2738681,142
Cashflow From Investing101.5%30*-2.02-20.18-8,9981.00-54.01-1.75-175*-17.45-19.67-30.84-140-157*---14.60-387-63.62-87.37-665-444
Cashflow From Financing-54.5%1,0452,2977509,0005,1342,8992321,99257888.002,5128222,4002,5671,8751,461-4104,1041,000-2,008
  Buy Backs----------------------

AVCO Income Statement

2023-09-30
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
RENTAL REVENUE$ 331,290$ 317,390$ 934,360$ 905,842
OPERATING EXPENSES288,083247,152781,931677,303
OPERATING INCOME43,20770,238152,429228,539
INCOME FROM EQUITY METHOD INVESTMENT - LAB SERVICES MSO354,500370,060
OTHER OPERATING EXPENSES:    
Advertising and marketing expenses437,750150,6201,634,720807,821
Professional fees435,144628,8072,659,8951,886,562
Compensation and related benefits469,959488,3731,375,6371,514,959
Research and development expenses170,406110,160541,566
Litigation settlement1,350,000
Other general and administrative expenses195,990221,131704,908687,243
Total Other Operating Expenses1,538,8431,659,3376,485,3206,788,151
LOSS FROM OPERATIONS(1,141,136)(1,589,099)(5,962,831)(6,559,612)
OTHER (EXPENSE) INCOME    
Interest expense - amortization of debt discount and debt issuance cost(199,136)(3,248,597)(290,794)(3,303,282)
Interest expense - other(229,144)(46,547)(527,702)(53,751)
Conversion inducement expense(344,264)(344,264)
Loss from equity method investment - Epicon(9,011)(18,564)(33,809)
Change in fair value of derivative liability87,173(168,520)128,894600,749
Impairment of equity method investment - Epicon(464,406)
Other income7,8802426,527260,701
Total Other Expense, net(343,939)(3,825,055)(1,189,045)(2,953,554)
LOSS BEFORE INCOME TAXES(1,485,075)(5,414,154)(7,151,876)(9,513,166)
INCOME TAXES
NET LOSS(1,485,075)(5,414,154)(7,151,876)(9,513,166)
LESS: NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST
NET LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS(1,485,075)(5,414,154)(7,151,876)(9,513,166)
COMPREHENSIVE LOSS:    
NET LOSS(1,485,075)(5,414,154)(7,151,876)(9,513,166)
OTHER COMPREHENSIVE LOSS    
Unrealized foreign currency translation loss(8,685)(37,033)(16,026)(78,515)
COMPREHENSIVE LOSS(1,493,760)(5,451,187)(7,167,902)(9,591,681)
LESS: COMPREHENSIVE LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST
COMPREHENSIVE LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS$ (1,493,760)$ (5,451,187)$ (7,167,902)$ (9,591,681)
NET LOSS PER COMMON SHARE ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS:    
Basic and diluted (in Dollars per share)$ (0.14)$ (0.56)$ (0.69)$ (1.04)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:    
Basic and diluted (in Shares)10,795,4899,703,60310,372,4479,152,168
Related Party    
OTHER (EXPENSE) INCOME    
Interest expense - related party$ (10,712)$ (8,358)$ (23,000)$ (79,898)

AVCO Balance Sheet

2023-09-30
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
CURRENT ASSETS:  
Cash$ 341,771$ 1,990,910
Rent receivable116,665134,626
Prepaid expense and other current assets405,599247,990
Total Current Assets864,0352,373,526
NON-CURRENT ASSETS:  
Operating lease right-of-use assets, net154,85410,885
Property and equipment, net40,334138,294
Investment in real estate, net7,233,5757,360,087
Equity method investments, net21,370,060485,008
Advances for equity interest purchase8,999,722
Other non-current assets304,323384,383
Total Non-current Assets29,103,14617,378,379
Total Assets29,967,18119,751,905
CURRENT LIABILITIES:  
Accrued professional fees1,730,2321,673,411
Accrued research and development fees891,751838,001
Accrued payroll liability and compensation385,754223,722
Accrued litigation settlement450,000450,000
Accrued liabilities and other payables383,287283,234
Operating lease obligation124,43811,437
Equity method investment payable1,000,000
Derivative liability41,048
Convertible note payable, net1,525,834
Total Current Liabilities6,691,8253,579,805
NON-CURRENT LIABILITIES:  
Operating lease obligation - noncurrent portion36,416
Accrued litigation settlement - noncurrent portion 450,000
Note payable, net5,566,4124,563,152
Total Non-current Liabilities6,452,8285,013,152
Total Liabilities13,144,6538,592,957
Commitments and Contingencies (Note 15)
EQUITY:  
Preferred stock value
Common stock, $0.0001 par value; 490,000,000 shares authorized; 10,981,534 shares issued and 10,929,534 shares outstanding at September 30, 2023; 10,013,576 shares issued and 9,961,576 shares outstanding at December 31, 20221,0981,005
Additional paid-in capital67,781,11265,949,723
Less: common stock held in treasury, at cost; 52,000 shares at September 30, 2023 and December 31, 2022(522,500)(522,500)
Accumulated deficit(70,214,597)(63,062,721)
Statutory reserve6,5786,578
Accumulated other comprehensive loss(229,163)(213,137)
Total Avalon GloboCare Corp. stockholders' equity16,822,52811,158,948
Non-controlling interest
Total Equity16,822,52811,158,948
Total Liabilities and Equity29,967,18119,751,905
Series A Convertible Preferred Stock  
EQUITY:  
Preferred stock value9,000,0009,000,000
Series B Convertible Preferred Stock  
EQUITY:  
Preferred stock value11,000,000
Related Parties  
CURRENT LIABILITIES:  
Accrued liabilities and other payables - related parties159,481100,000
NON-CURRENT LIABILITIES:  
Loan payable - related party$ 850,000
AVCO
0
 WEBSITEwww.avalon-globocare.com

Avalon GloboCare Corp Frequently Asked Questions


What is the ticker symbol for Avalon GloboCare Corp? What does AVCO stand for in stocks?

AVCO is the stock ticker symbol of Avalon GloboCare Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Avalon GloboCare Corp (AVCO)?

As of Wed Feb 21 2024, market cap of Avalon GloboCare Corp is 4.29 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AVCO stock?

You can check AVCO's fair value in chart for subscribers.

What is the fair value of AVCO stock?

You can check AVCO's fair value in chart for subscribers. The fair value of Avalon GloboCare Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Avalon GloboCare Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AVCO so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Avalon GloboCare Corp a good stock to buy?

The fair value guage provides a quick view whether AVCO is over valued or under valued. Whether Avalon GloboCare Corp is cheap or expensive depends on the assumptions which impact Avalon GloboCare Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AVCO.

What is Avalon GloboCare Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Feb 21 2024, AVCO's PE ratio (Price to Earnings) is -0.45 and Price to Sales (PS) ratio is 112.06. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AVCO PE ratio will change depending on the future growth rate expectations of investors.